{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T20:19:03Z","timestamp":1789935543715,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Jagiellonian University in Cracow","award":["K\/ZDS\/001812"],"award-info":[{"award-number":["K\/ZDS\/001812"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.bone.2018.08.007","type":"journal-article","created":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T06:58:09Z","timestamp":1534402689000},"page":"387-392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Sclerostin and its significance for children and adolescents with type 1 diabetes mellitus (T1D)"],"prefix":"10.1016","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0864-6810","authenticated-orcid":false,"given":"Anna","family":"W\u0119drychowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystyna","family":"Sztefko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy B.","family":"Starzyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2018.08.007_bb0005","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.tem.2008.02.006","article-title":"Reciprocal regulation of bone and energy metabolism","volume":"19","author":"Lee","year":"2008","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bone.2018.08.007_bb0010","first-page":"365","article-title":"Fat targets for skeletal health","volume":"5","author":"Kawai","year":"2009","journal-title":"Nat. Rev."},{"key":"10.1016\/j.bone.2018.08.007_bb0015","first-page":"21","article-title":"A paradigm between serum osteocalcin and markers of metabolic phenotype","volume":"310","author":"Cofavreux","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bone.2018.08.007_bb0020","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1161\/ATVBAHA.110.204859","article-title":"Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome","volume":"30","author":"Saleem","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bone.2018.08.007_bb0025","first-page":"491","article-title":"Associations between bone, fat tissue and metabolic control in children and adolescents with type 1 diabetes mellitus","volume":"122","author":"W\u0119drychowicz","year":"2014","journal-title":"ECED Diabetes"},{"key":"10.1016\/j.bone.2018.08.007_bb0030","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1210\/en.2007-0270","article-title":"Targeting the Wnt\/beta-catenin pathway to regulate bone formation in the adult skeleton","volume":"148","author":"Baron","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2018.08.007_bb0035","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1172\/JCI28551","article-title":"Regulation of bone mass by Wnt signaling","volume":"116","author":"Krishnan","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2018.08.007_bb0040","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ajmg.10401","article-title":"A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population","volume":"110","author":"Staehling-Hampton","year":"2002","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bone.2018.08.007_bb0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/jmg.39.2.91","article-title":"Identification of a 52\u202fkb deletion downstream of the SOST gene in patients with van Buchem disease","volume":"39","author":"Balemans","year":"2002","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bone.2018.08.007_bb0050","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1359\/jbmr.081206","article-title":"Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis","volume":"24","author":"Li","year":"2009","journal-title":"JBMR"},{"key":"10.1016\/j.bone.2018.08.007_bb0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jbmr.173","article-title":"Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody","volume":"26","author":"Padhi","year":"2011","journal-title":"JBMR"},{"key":"10.1016\/j.bone.2018.08.007_bb0060","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1210\/me.2007-0259","article-title":"Gone with the Wnts: \u03b2-catenin, T-cell factor, forkhead box O, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism","volume":"21","author":"Manolagas","year":"2007","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.bone.2018.08.007_bb0065","doi-asserted-by":"crossref","DOI":"10.1038\/srep00693","article-title":"Importance of \u03b2-catenin in glucose and energy homeostasis","volume":"2","author":"Elghazi","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bone.2018.08.007_bb0070","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.2337\/dc12-1691","article-title":"Atherosclerotic disease in type 2 diabetes is associated with an increase in sclerostin levels","volume":"36","author":"Morales-Santana","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bone.2018.08.007_bb0075","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/jc.2011-2186","article-title":"Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus","volume":"97","author":"Garc\u00eda-Mart\u00edn","year":"2012","journal-title":"JCEM"},{"key":"10.1016\/j.bone.2018.08.007_bb0080","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1210\/jc.2011-2958","article-title":"Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes","volume":"97","author":"Gennari","year":"2012","journal-title":"JCEM"},{"key":"10.1016\/j.bone.2018.08.007_bb0085","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.diabet.2016.09.009","article-title":"Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes","volume":"43","author":"Catalano","year":"2017","journal-title":"Diabete Metab."},{"key":"10.1016\/j.bone.2018.08.007_bb0090","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/cen.12364","article-title":"Clinical and endocrine correlates of circulating sclerostin levels in patients with type 1 diabetes mellitus","volume":"80","author":"Neumann","year":"2014","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.bone.2018.08.007_bb0095","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/pedi.12288","article-title":"Sclerostin distribution in children and adolescents with type 1 diabetes mellitus and correlation with bone metabolism markers and bone mineral density","volume":"17","author":"Tsentidis","year":"2016","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.bone.2018.08.007_bb0100","series-title":"Siatki centylowe do oceny rozwoju somatycznego dzieci i m\u0142odzie\u017cy","author":"Palczewska","year":"1999"},{"key":"10.1016\/j.bone.2018.08.007_bb0105","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/ijo.2009.282","article-title":"A new link between skeleton, obesity and insulin resistance: relationships between osteocalcin, leptin and insulin resistance in obese children before and after weight loss","volume":"34","author":"Reinehr","year":"2010","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.bone.2018.08.007_bb0110","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2337\/dc09-1837","article-title":"Carboxylation of osteocalcin affects its association with metabolic parameters in healthy children","volume":"33","author":"Prats-Puig","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bone.2018.08.007_bb0115","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/dc14-2989","article-title":"Sclerostin and insulin resistance in prediabetes: evidence of a cross talk between bone and glucose metabolism","volume":"38","author":"Daniele","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bone.2018.08.007_bb0120","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1210\/jc.2010-0720","article-title":"Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women","volume":"95","author":"Drake","year":"2010","journal-title":"JCEM"},{"key":"10.1016\/j.bone.2018.08.007_bb0125","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2018.08.007_bb0130","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.bone.2004.05.023","article-title":"Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation","volume":"35","author":"Sutherland","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.bone.2018.08.007_bb0135","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1210\/jc.2010-0067","article-title":"Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss","volume":"95","author":"Gaudio","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2018.08.007_bb0140","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1182\/blood-2017-03-773341","article-title":"Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma","volume":"29","author":"McDonald","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bone.2018.08.007_bb0145","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.numecd.2010.07.008","article-title":"Mechanisms of impaired bone strength- in type 1 and 2 diabetes","volume":"20","author":"Merlotti","year":"2010","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.bone.2018.08.007_bb0150","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jc.2016-2371","article-title":"High sclerostin and Dickkopf-1 (DKK-1) serum levels in children and adolescents with type 1 diabetes mellitus","volume":"102","author":"Faienza","year":"2017","journal-title":"JCEM"},{"key":"10.1016\/j.bone.2018.08.007_bb0155","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00198-011-1669-z","article-title":"Sclerostin levels during growth in children","volume":"23","author":"Kirmani","year":"2012","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2018.08.007_bb0160","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1530\/EJE-14-0106","article-title":"Gender differences in sclerostin and clinical characteristics in type 1 diabetes mellitus","volume":"171","author":"Catalano","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bone.2018.08.007_bb0165","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4103\/1110-161X.128136","article-title":"Type 2 diabetes raises serum sclerostin levels and disturbs the relation between sclerostin and bone mineral density: a call for caution with antisclerostin therapy in osteoporosis","volume":"41","author":"Al-Zifzafa","year":"2014","journal-title":"Egypt. Rheumatol. Rehabil."},{"key":"10.1016\/j.bone.2018.08.007_bb0170","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.cell.2009.06.051","article-title":"A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure","volume":"138","author":"Yadaw","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.bone.2018.08.007_bb0175","first-page":"209","article-title":"Role of leptin in diabetes mellitus","volume":"1","author":"Ravipati","year":"2011","journal-title":"Ind. J. Fund. Appl. Life Sci."},{"key":"10.1016\/j.bone.2018.08.007_bb0180","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diabetes.48.7.1487","article-title":"Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat","volume":"48","author":"Chinookoswong","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.bone.2018.08.007_bb0185","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s00125-003-1193-6","article-title":"Leptin as an adjunct on insulin therapy in insulin-deficient diabetes","volume":"46","author":"Miyanaga","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.bone.2018.08.007_bb0190","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1073\/pnas.0909422107","article-title":"Leptin therapy in insulin-deficient type I diabetes","volume":"107","author":"Wang","year":"2010","journal-title":"PNAS"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328218303089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328218303089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T20:57:29Z","timestamp":1604782649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328218303089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":38,"alternative-id":["S8756328218303089"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2018.08.007","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sclerostin and its significance for children and adolescents with type 1 diabetes mellitus (T1D)","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2018.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}